Utility of tolerance assays for real-time management of infliximab infusion reactions
{{output}}
Failure of infliximab (IFX) therapy is often associated with pharmacokinetic challenges, frequently linked to the development of anti-infliximab antibodies (ATI). ATI formation is a key factor contributing to therapeutic failure and significant safety concerns... ...
